Table 3.

Incremental cost-effectiveness analysis (direct medical costs and clinical effects of patients treated with alternatives therapies)

Treatments	Costs*	Costs ▲†	Effectiveness‡	Effectiveness▲	ACER**	ICER††
Celecoxib	6,524.6		371		17.595
Nonselective NSAIDs	6,587.4	62.8	274	97	24.033	Dominance
Acetaminophen	7,026.7	502.1	270	101	26.029	Dominance

*Estimated costs by patient (Mexican pesos).

^†Incremental costs.

^‡Number of patients with pain control without adverse events.

**Average cost-effectiveness ratio.

^††Incremental cost-effectiveness ratio.

NSAIDs, nonsteroidal anti-inflammatory drugs.